Takeda Pharmaceutical
TAK
#489
Rank
A$70.61 B
Marketcap
A$21.98
Share price
0.07%
Change (1 day)
4.93%
Change (1 year)

Operating Margin for Takeda Pharmaceutical (TAK)

Operating Margin as of July 2025 (TTM): 6.76%

According to Takeda Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 6.76%. At the end of 2024 the company had an Operating Margin of 1.24%.

Operating Margin history for Takeda Pharmaceutical from 2009 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
20241.24%-86.71%
20239.31%9.86%
20228.48%-25.98%
202111.45%-720.42%
2020-1.85%-130.34%
20196.08%-50.4%
201812.27%48.23%
20178.28%24.09%
20166.67%-181.53%
2015-8.18%-187.12%
20149.39%9.87%
20138.55%-48.92%
201216.73%-36.08%
201126.18%-7.71%
201028.37%9.49%
200925.91%-38.25%
200841.96%-12.43%
200747.92%12.14%
200642.73%8.78%
200539.28%-4.35%
200441.07%-0.54%
200341.29%11.12%
200237.15%36.07%
200127.30%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
18.78% 177.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
15.12% 123.67%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
12.60% 86.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
28.02% 314.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-30.69%-553.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
23.99% 254.88%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
19.48% 188.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
13.32% 97.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
31.06% 359.47%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.